Related Experiment Video

Updated: Aug 15, 2026

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States
07:09

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States

Published on: April 1, 2015

[Homocysteine and diabetes]

Aleksander Januła1, Bogdan Marek, Dariusz Kajdaniuk

  • 1Zakładu Patofizjologii Katedry Patofizjologii i Endokrynologii, Zabrzu.

Wiadomosci Lekarskie (Warsaw, Poland : 1960)
|October 22, 2005
PubMed

Insights

High homocysteine levels (hyperhomocysteinemia) are an independent risk factor for vascular disease. This review explores its specific role in diabetes, particularly in relation to vascular complications.

Area of Science:

  • Cardiovascular Science
  • Endocrinology
  • Metabolic Disease

Context:

  • Hyperhomocysteinemia is an emerging risk factor for atherosclerosis and cardiovascular diseases.
  • The specific mechanisms linking hyperhomocysteinemia to diabetes remain unclear.
  • Understanding this link is crucial for managing diabetic complications.

Purpose:

  • To review current knowledge on hyperhomocysteinemia's role in vascular changes.
  • To investigate the unexplained connection between hyperhomocysteinemia and diabetes.
  • To elucidate how hyperhomocysteinemia influences diabetic macro- and microangiopathy.

Summary:

  • Elevated serum homocysteine (hyperhomocysteinemia) is an independent risk factor for arteriosclerosis and cardiovascular diseases.
  • The precise role of hyperhomocysteinemia in diabetes is not fully understood.
  • It likely impacts diabetes management and complications through macro- and microangiopathy development.

Impact:

  • Provides a comprehensive overview of hyperhomocysteinemia in vascular disease, with a focus on diabetes.
  • Highlights the need for further research into the mechanisms of hyperhomocysteinemia in diabetic patients.
  • Informs clinical practice regarding the assessment and management of cardiovascular risk in diabetics with hyperhomocysteinemia.

More Related Videos

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension05:57

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension

Published on: May 17, 2024

Related Concept Videos

Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes Mellitus: Introduction01:26

Diabetes Mellitus: Introduction

Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...